Is Liraglutide legal in Massachusetts?
status · no specific restrictions
FDA-approved GLP-1 receptor agonist (Victoza/Saxenda); FDA proposed April 2026 to exclude from 503B bulks list; intermittent shortage 2023-Q3 2024. No state-level peptide restrictions beyond federal law in Massachusetts.
category: fda approved · last verified May 13, 2026
§ 01
Quick answer
FDA-approved GLP-1 receptor agonist (Victoza/Saxenda); FDA proposed April 2026 to exclude from 503B bulks list; intermittent shortage 2023-Q3 2024. No state-level peptide restrictions beyond federal law in Massachusetts.
§ 02
Full status breakdown
Federal status
FDA approval
approved as drug · brand: Victoza, Saxenda · NDA 022341 (Victoza); NDA 206321 (Saxenda) · approved Jan 25, 2010
Indications: T2DM (Victoza); chronic weight management (Saxenda); CV risk reduction in T2D with CVD
DEA scheduling
not scheduled
503A compounding
Bulks list: not on list
Do-not-compound list: not on list
Approved drug for which USP/NF monograph exists; not a §503A bulks candidate. FDA proposed April 2026 exclusion from 503B bulks list alongside semaglutide and tirzepatide.
FDA Warning Letters
none on record for this compound
Shortage status
Sale framing
Research-use-only posture: Liraglutide is FDA-approved; selling as 'research peptide' misrepresents an approved drug and exposes seller to FDCA §301 misbranding and DOJ unapproved-diversion enforcement.
Personal possession: Not federally criminalized (not a controlled substance). Possession of unapproved or counterfeit liraglutide is a regulatory rather than criminal matter at the federal level.
Massachusetts — state-specific
Sport-body status
WADA 2026
on prohibited list · class S2 · both
GLP-1 receptor agonists moved from monitoring to full prohibition January 2026. Captured under S2 class language.
USADA
banned
NCAA
unknown
What we couldn’t verify
§ 03
Also known as
Liraglutide is also marketed or referenced under the following names (vendor pseudonyms, brand names, chemical identifiers):
SaxendaVictozaNN2211Lira
§ 04
Disclaimer
§ 05
Related
- Back to peptide legality lookup — pick a different compound or state
- Peptide pricing index — what each compound costs per mg across audited vendors
- Janoshik COA verifier — a separate question from legality: does the COA the vendor cites actually exist?
the roundup · monthly
Receipts in your inbox. Once a month.
New audits, expired coupons pruned, lab notes from vials still on the bench. No marketing. No lifestyle copy. Unsubscribe in one click.
14,200 subscribers· 0 sponsored items· 11 issues since launch